These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 38011984
1. Nebulised 3% hypertonic saline versus 0.9% saline for treating patients hospitalised with acute bronchiolitis: protocol for a randomised, double-blind, multicentre trial. Szupieńko S, Buczek A, Szymański H. BMJ Open; 2023 Nov 27; 13(11):e080182. PubMed ID: 38011984 [Abstract] [Full Text] [Related]
8. SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis. Everard ML, Hind D, Ugonna K, Freeman J, Bradburn M, Cooper CL, Cross E, Maguire C, Cantrill H, Alexander J, McNamara PS, SABRE Study Team. Thorax; 2014 Dec 21; 69(12):1105-12. PubMed ID: 25389139 [Abstract] [Full Text] [Related]
9. Efficacy of Nebulized Hypertonic Saline (3%) Versus Normal Saline and Salbutamol in Treating Acute Bronchiolitis in A Tertiary Hospital: A Randomized Controlled Trial. Pandit P, Hoque MA, Pandit H, Dhar SK, Mondal D, Ahmad F. Mymensingh Med J; 2022 Apr 21; 31(2):295-303. PubMed ID: 35383741 [Abstract] [Full Text] [Related]
11. Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months. Enriquez A, Chu IW, Mellis C, Lin WY. Cochrane Database Syst Rev; 2012 Nov 14; 11(11):CD008395. PubMed ID: 23152257 [Abstract] [Full Text] [Related]
12. Epinephrine Improves the Efficacy of Nebulized Hypertonic Saline in Moderate Bronchiolitis: A Randomised Clinical Trial. Flores-González JC, Matamala-Morillo MA, Rodríguez-Campoy P, Pérez-Guerrero JJ, Serrano-Moyano B, Comino-Vazquez P, Palma-Zambrano E, Bulo-Concellón R, Santos-Sánchez V, Lechuga-Sancho AM, Bronchiolitis of Cadiz Study group (BronCaS). PLoS One; 2015 Nov 14; 10(11):e0142847. PubMed ID: 26575036 [Abstract] [Full Text] [Related]
16. Nebulised hypertonic saline in children with bronchiolitis admitted to the paediatric intensive care unit: A retrospective study. Stobbelaar K, Kool M, de Kruijf D, Van Hoorenbeeck K, Jorens P, De Dooy J, Verhulst S. J Paediatr Child Health; 2019 Sep 14; 55(9):1125-1132. PubMed ID: 30645038 [Abstract] [Full Text] [Related]
17. Nebulized hypertonic saline for bronchiolitis: a randomized clinical trial. Wu S, Baker C, Lang ME, Schrager SM, Liley FF, Papa C, Mira V, Balkian A, Mason WH. JAMA Pediatr; 2014 Jul 14; 168(7):657-63. PubMed ID: 24862623 [Abstract] [Full Text] [Related]
19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A, Chua JV, Talwani R, Bentzen SM, Baddley J. Trials; 2020 Oct 28; 21(1):897. PubMed ID: 33115543 [Abstract] [Full Text] [Related]
20. Effect of Nebulized Hypertonic Saline Treatment in Emergency Departments on the Hospitalization Rate for Acute Bronchiolitis: A Randomized Clinical Trial. Angoulvant F, Bellêttre X, Milcent K, Teglas JP, Claudet I, Le Guen CG, de Pontual L, Minodier P, Dubos F, Brouard J, Soussan-Banini V, Degas-Bussiere V, Gatin A, Schweitzer C, Epaud R, Ryckewaert A, Cros P, Marot Y, Flahaut P, Saunier P, Babe P, Patteau G, Delebarre M, Titomanlio L, Vrignaud B, Trieu TV, Tahir A, Regnard D, Micheau P, Charara O, Henry S, Ploin D, Panjo H, Vabret A, Bouyer J, Gajdos V, Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis (GUERANDE) Study Group. JAMA Pediatr; 2017 Aug 07; 171(8):e171333. PubMed ID: 28586918 [Abstract] [Full Text] [Related] Page: [Next] [New Search]